CO6761363A2 - Masa de chocolate - Google Patents

Masa de chocolate

Info

Publication number
CO6761363A2
CO6761363A2 CO13158420A CO13158420A CO6761363A2 CO 6761363 A2 CO6761363 A2 CO 6761363A2 CO 13158420 A CO13158420 A CO 13158420A CO 13158420 A CO13158420 A CO 13158420A CO 6761363 A2 CO6761363 A2 CO 6761363A2
Authority
CO
Colombia
Prior art keywords
content
chocolate dough
chocolate
chocolate mass
dough
Prior art date
Application number
CO13158420A
Other languages
English (en)
Inventor
Johannes Coy
Original Assignee
Md & D Alliance Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Md & D Alliance Gmbh filed Critical Md & D Alliance Gmbh
Publication of CO6761363A2 publication Critical patent/CO6761363A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A23G1/40—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A23G1/42—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G1/426—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
    • A23V2250/608—Galactose
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
    • A23V2250/62—Palatinose, isomaltulose
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
    • A23V2250/634—Tagatose
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
    • A23V2250/636—Trehalose
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/70—Vitamins
    • A23V2250/712—Vitamin E

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Confectionery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención proporciona una nueva masa de chocolate que tiene un índice glucémico menor de 29 (IG < 29) y cuyo contenido de azúcar añadido comprende al menos el 10 % de galactosa y además tiene un contenido de isomaltulosa y/o tagatosa. Adicionalmente la masa de chocolate tiene un contenido de vitamina E en forma de una mezcla de tocotrienol-tocoferol procedente de fuentes naturales, en la que el contenido de tocotrienoles en la masa de chocolate es mayor que el contenido de tocoferoles.
CO13158420A 2011-01-06 2013-07-04 Masa de chocolate CO6761363A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102011008016A DE102011008016A1 (de) 2011-01-06 2011-01-06 Schokoladenmasse

Publications (1)

Publication Number Publication Date
CO6761363A2 true CO6761363A2 (es) 2013-09-30

Family

ID=46025274

Family Applications (1)

Application Number Title Priority Date Filing Date
CO13158420A CO6761363A2 (es) 2011-01-06 2013-07-04 Masa de chocolate

Country Status (16)

Country Link
US (1) US10694761B2 (es)
EP (1) EP2590514B1 (es)
CN (1) CN103491796B (es)
BR (1) BR112013017370B1 (es)
CL (1) CL2013001989A1 (es)
CO (1) CO6761363A2 (es)
DE (1) DE102011008016A1 (es)
EA (1) EA023842B1 (es)
ES (1) ES2517465T3 (es)
MX (1) MX2013007882A (es)
PE (1) PE20140499A1 (es)
PL (1) PL2590514T3 (es)
SG (1) SG191405A1 (es)
UA (1) UA91011U (es)
WO (1) WO2012092916A1 (es)
ZA (1) ZA201304348B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012017884A1 (de) * 2012-08-03 2014-02-20 Krüger Gmbh & Co. Kg Zusammensetzung für die retardierte Resorption
WO2014083161A1 (en) * 2012-11-29 2014-06-05 Nestec S.A. Increasing the bioavailability of flavan-3-ols with carbohydrates with a low glycemic index
AU2014240467B2 (en) * 2013-03-14 2018-11-29 University Of Florida Research Foundation, Incorporated Regulation of cancer using natural compounds and/or diet
WO2015162447A1 (en) * 2014-04-25 2015-10-29 Nexira International Use of a composition comprising arabic gum (ag) for improving gut impermeability
CH710346A1 (it) * 2014-11-07 2016-05-13 Tassone Agostino Composizione nutraceutica di alimenti.
US11020372B2 (en) 2015-03-24 2021-06-01 University Of Florida Research Foundation, Incorporated Dietary and natural product management of negative side effects of cancer treatment
RU2620636C2 (ru) * 2015-07-06 2017-05-29 Валерий Анатольевич Алиев Состав для приготовления мягкого шоколада и способ приготовления мягкого шоколада из этого состава
CN105594949A (zh) * 2015-12-21 2016-05-25 长春大学 一种添加天然植物性类***的巧克力及生产方法
US11224234B2 (en) 2016-11-10 2022-01-18 Immd Sp. Z.O.O. Functional chocolate
CN107410626A (zh) * 2017-04-14 2017-12-01 安徽兆龙食品有限公司 一种含有茶多酚的巧克力及其制备方法
IT201800009489A1 (it) * 2018-10-16 2020-04-16 Ens Srl - European Nutritional Supplements Srl Matrice di cioccolato comprendente curcumina e resveratrolo
CN111436514A (zh) * 2020-03-06 2020-07-24 华南农业大学 一种肉桂精油生巧克力及其制备方法
RU2752921C1 (ru) * 2020-11-16 2021-08-11 Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный технологический университет" (ФГБОУ ВО "КубГТУ") Шоколадная масса для получения шоколада специализированного назначения
IT202100021053A1 (it) * 2021-08-04 2023-02-04 Noi Nora Damonti Crema dolce ad uso alimentare
EP4298916A1 (en) * 2022-06-28 2024-01-03 Volodymyr Mandrin Chocolate product

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE381799B (sv) 1972-08-18 1975-12-22 Semper Ab Forfarande for framstellning av s.k. "crumb" for tillverkning av mjolkchoklad
DE3689071T2 (de) * 1985-10-31 1994-02-10 Univ Australian Immunheilbehandlung.
JPH05339148A (ja) * 1992-05-28 1993-12-21 T Knight Albert 血液脳関門を通過する物質
AU6165894A (en) * 1993-01-28 1994-08-15 Trustees Of The University Of Pennsylvania, The Use of creatine or analogs for the manufacture of a medicament for inhibiting tumor growth
EP1719510A1 (en) * 1994-11-08 2006-11-08 Avicenda Group, Inc. Use of creatine or creatine analogs for the tratment of diseases of the nervous system
US7202219B1 (en) * 1998-02-24 2007-04-10 Md Foods Amba Use of D-tagatose as a prebiotic food component
US20050085498A1 (en) * 1998-05-28 2005-04-21 Byrd Edward A. Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate
EP1100589B1 (en) * 1998-07-30 2005-01-19 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Use of propionyl l-carnitine and acetyl l-carnitine in the preparation of medicaments with anticancer activity
JP2001192342A (ja) * 2000-01-07 2001-07-17 Ta Stevia Co Ltd ステビア濃縮液剤および成熟ざくろ混合物の製造方法
US6608103B2 (en) * 2001-02-08 2003-08-19 Fuji Chemical Industry Co., Ltd. Inhibitor for neovasculation, cell multiplication, lumen formation and FGF
US6416797B1 (en) * 2001-02-14 2002-07-09 Kraft Foods Holdings, Inc. Process for making a wheyless cream cheese using transglutaminase
US20040044028A1 (en) * 2001-03-30 2004-03-04 Obukowicz Mark G. Combinations of omega-3 fatty acids and cyclooxygenase-2 inhibitors for treatment or prevention of cardiovascular disease and treatment or prevention of cancer
US6572901B2 (en) * 2001-05-02 2003-06-03 Kraft Foods Holdings, Inc. Process for making a cheese product using transglutaminase
US20030119879A1 (en) * 2001-10-15 2003-06-26 Thomas Landh Nicotine and chocolate compositions
JP3643932B2 (ja) * 2001-10-31 2005-04-27 味の素株式会社 チーズカードの製造方法
US8529956B2 (en) * 2002-03-18 2013-09-10 Carnell Therapeutics Corporation Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
TWI337868B (en) * 2004-05-21 2011-03-01 Tzu Chi Buddhist General Hospital Method for extracting extract from chaenomeles lagenaria and the applications thereof
EP1841779A2 (fr) * 2005-01-28 2007-10-10 Barry Callebaut AG Utilisation de polyphenols du cacao pour le traitement de l'hyperplasie de la prostate, extrait de cacao, specifique et applications
AU2006222277B2 (en) 2005-03-07 2011-04-07 Johannes Coy Method for checking and controlling the mammalian lactic acid fermentation process/aerobic glucose fermentation metabolic pathway in mammalian organism
EP1701165A1 (en) * 2005-03-07 2006-09-13 Johannes Dr. Coy Therapeutic and diagnostic uses of TKTL1 and inhibitors and activators thereof
DE102005034043B4 (de) * 2005-07-18 2019-12-12 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Gemisch, enthaltend L-Carnitin und Trehalulose, sowie Produkt enthaltend das Gemisch
CN101263391A (zh) * 2005-09-12 2008-09-10 菲诺梅诺米发现公司 通过测量维生素e-相关的代谢物诊断结肠直肠癌和卵巢癌的方法
WO2007035311A2 (en) * 2005-09-16 2007-03-29 University Of Massachusetts Lowell Anti-oxidant synergy formulation nanoemulsions to treat cancer
ES2706281T3 (es) 2005-12-20 2019-03-28 Nutricia Nv Composición de carbohidratos y respuesta disminuida de glucosa
CN102846589A (zh) * 2005-12-24 2013-01-02 帝斯曼知识产权资产管理有限公司 长期体重维持
EP2010199A4 (en) * 2006-03-17 2009-12-16 Herbalscience Singapore Pte Ltd EXTRACTS AND METHODS CONTAINING CURCUMA SPECIES
DE102006014543A1 (de) 2006-03-21 2007-09-27 Südzucker AG Mannheim/Ochsenfurt Funktionelle Lebensmittel gegen Tumore
US7879370B2 (en) * 2006-04-26 2011-02-01 Merican Corporation Composition of which chief ingredient is polysaccharides having an immunoregulatory function
CN101077356B (zh) * 2006-05-24 2010-12-01 上海中医药大学 一种蜈蚣藻多糖提取物在制备抗肿瘤药物中的应用
US8017147B2 (en) * 2008-04-07 2011-09-13 Mazed Mohammad A Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance
ES2604081T3 (es) * 2007-01-10 2017-03-02 Dsm Nutritional Products Ag Microcápsulas que incluyen proteína de guisante
US7972633B2 (en) * 2007-02-07 2011-07-05 Applied Cognitive Sciences, LLC Nutritional supplements for healthy memory and mental function
EP1982601A1 (en) * 2007-04-17 2008-10-22 Nestec S.A. Reduced sugar ice confection
US20080260925A1 (en) 2007-04-23 2008-10-23 Galen Paul Zink Means for replacing common sugars if foods for enhanced nutrition
EP2155888B1 (en) * 2007-05-24 2014-07-09 Loders Croklaan B.V. Process for producing compositions comprising tocopherols and tocotrienols
US20090104171A1 (en) * 2007-10-19 2009-04-23 Pardee Joel D Metabolic Enhancement Therapy
WO2009057994A1 (en) * 2007-11-02 2009-05-07 N.V. Nutricia Unit dosage for brain health
JP5358952B2 (ja) * 2008-01-10 2013-12-04 和光純薬工業株式会社 膵臓癌マーカーおよび膵臓癌の検査方法
US20090209486A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown Compositions of carbohydrates as dietary supplements
CN102065845A (zh) * 2008-06-11 2011-05-18 阿斯利康(瑞典)有限公司 含有(2s)-(4e)-n-甲基-5-(5-异丙氧基吡啶-3-基)-戊-4-烯-2-胺的舌下组合物
CN101422439A (zh) * 2008-11-14 2009-05-06 李铁军 一种注射用依托泊苷冻干粉针制剂及其制备方法
US20110306579A1 (en) * 2009-01-30 2011-12-15 Emory University Methods of neuroprotection using neuroprotective steroids and a vitamin d
CN101822808A (zh) * 2009-03-02 2010-09-08 高汉卿 一种用中草药热敷***的外用药物
WO2010104374A1 (en) * 2009-03-09 2010-09-16 N.V. Nutricia Nutritional composition inducing a postprandial endocrine response
EP2413717B1 (en) 2009-04-01 2014-06-04 Sanset Gida Turizm Sanayi Ve Ticaret Anonim Sirketi Dietary chocolate compositions and production method thereof
US20130136800A1 (en) * 2010-03-31 2013-05-30 Vegenat, S.A. Enteral Or Oral Food Product Intended, In Particular, For nutrition And For The Prevention And Improvement Of Neurological Alterations, Neurodegenerative Alterations or Cognitive Disorders

Also Published As

Publication number Publication date
SG191405A1 (en) 2013-08-30
CL2013001989A1 (es) 2014-02-07
PE20140499A1 (es) 2014-05-15
EA023842B1 (ru) 2016-07-29
ES2517465T3 (es) 2014-11-03
ZA201304348B (en) 2014-02-26
US20130280357A1 (en) 2013-10-24
DE102011008016A1 (de) 2012-07-12
CN103491796A (zh) 2014-01-01
CN103491796B (zh) 2014-10-08
EP2590514B1 (de) 2014-08-06
BR112013017370B1 (pt) 2018-07-17
EA201300672A1 (ru) 2013-12-30
EP2590514A1 (de) 2013-05-15
BR112013017370A2 (pt) 2017-10-17
WO2012092916A1 (de) 2012-07-12
MX2013007882A (es) 2013-11-20
US10694761B2 (en) 2020-06-30
PL2590514T3 (pl) 2015-02-27
UA91011U (uk) 2014-06-25

Similar Documents

Publication Publication Date Title
CO6761363A2 (es) Masa de chocolate
PH12019500518A1 (en) Oligosaccharide mixture and food product comprising this mixture, especially infant formula
CO6761400A2 (es) Combinación de análogos de glucagón acilados con análogos de insulina
PH12018500767A1 (en) Pharmaceutical composition, methods for treating and uses thereof
MX2019008380A (es) Composiciones de arni contra el componente c5 del complemento y metodos para su uso.
BR112013017154A2 (pt) uso de fitocanabinóide canabidiol (cbd) em combinação com um fármaco antiepiléptico padrão (saed) no tratamento de epilepsia
EA033286B1 (ru) Способ лечения или отсрочки развития хронической болезни почек
UY34701A (es) Formas sólidas de un profármaco de nucleótidos de tiofosforamidato
WO2014022739A3 (en) Modified rnai agents
EA201101189A1 (ru) Ингибитор sglt-2, предназначенный для лечения сахарного диабета типа 1, сахарного диабета типа 2, нарушенной толерантности к глюкозе или гипергликемии
BR112016002233A2 (pt) composições de adoçante
NZ620326A (en) Cd37 immunotherapeutic combination therapies and uses thereof
SG10201804472YA (en) SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
TW200714277A (en) Methods and compositions for altering cell fuction
BR112019001602A2 (pt) composição de açúcar
MX360554B (es) Composiciones que comprenden y metodos que utilizan inhibidores de co-transportadores de glucosa-sodio 1 y 2.
MX2013008500A (es) Disialillacto-n-tetraosa (dslnt) o variantes, isomeros, analogos y derivados de la misma para prevenir o inhibir la enfermedad del intestino.
BR112016008352A2 (pt) processo para a produção de polibutadienos catalisados com neodímio (ndbr), misturas de borracha que contêm polibutadienos catalisados com neodímio (ndbr), e usos de misturas de borracha
WO2014153009A3 (en) Thiosaccharide mucolytic agents
EP4137147A3 (en) Uses of abaloparatide in reducing fracture risk
MX357166B (es) Anticuerpos que se unen a notum pectinacetilesterasa.
UY33208A (es) Composiciones que comprenden productos de azúcar cisteína
MY164337A (en) Chocolate
MX2016002714A (es) Composicion y metodo para tropicalizar chocolate.
NZ613887A (en) Antimicrobial activity enhancing agent